Bosl G - Search Results

1

Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.

Singh B, Stoffel A, Gogineni S, Poluri A, Pfister DG, Shaha AR, Pathak A, Bosl G, Cordon-Cardo C, Shah JP, Rao PH. Singh B, et al. Among authors: bosl g. Am J Pathol. 2002 Aug;161(2):365-71. doi: 10.1016/S0002-9440(10)64191-0. Am J Pathol. 2002. PMID: 12163360 Free PMC article.

2

Analysis of chromosome 12 aneuploidy in interphase cells from human male germ cell tumors by fluorescence in situ hybridization.

Rodriguez E, Mathew S, Mukherjee AB, Reuter VE, Bosl GJ, Chaganti RS. Rodriguez E, et al. Among authors: bosl gj. Genes Chromosomes Cancer. 1992 Jul;5(1):21-9. doi: 10.1002/gcc.2870050104. Genes Chromosomes Cancer. 1992. PMID: 1384658

3

Current status of larynx preservation with multimodality therapy.

Pfister DG, Harrison LB, Strong EW, Bosl GJ. Pfister DG, et al. Among authors: bosl gj. Oncology (Williston Park). 1992 Mar;6(3):33-8, 43; discussion 44, 47. Oncology (Williston Park). 1992. PMID: 1533144

4

BOMM: new solution or old problem?

Pfister DG, Bosl GJ. Pfister DG, et al. Among authors: bosl gj. Cancer Invest. 1991;9(5):605-6. doi: 10.3109/07357909109018960. Cancer Invest. 1991. PMID: 1718578 No abstract available.

5

Chemotherapy as part of the initial treatment for nasopharyngeal cancer.

Harrison LB, Pfister DG, Bosl GJ. Harrison LB, et al. Among authors: bosl gj. Oncology (Williston Park). 1991 Feb;5(2):67-70;discussion 70-1,74,79 passim. Oncology (Williston Park). 1991. PMID: 1826210 Review.

6

Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies.

Motzer RJ, Rodriguez E, Reuter VE, Samaniego F, Dmitrovsky E, Bajorin DF, Pfister DG, Parsa NZ, Chaganti RS, Bosl GJ. Motzer RJ, et al. Among authors: bosl gj. J Natl Cancer Inst. 1991 Mar 6;83(5):341-6. doi: 10.1093/jnci/83.5.341. J Natl Cancer Inst. 1991. PMID: 1847433

7

Chemotherapy and the management of locally advanced squamous cell carcinoma of the head and neck: role in larynx preservation.

Bosl GJ, Strong E, Harrison L, Pfister DG. Bosl GJ, et al. Important Adv Oncol. 1991:191-203. Important Adv Oncol. 1991. PMID: 1869277 Review. No abstract available.

8

Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer.

Harrison LB, Pfister DG, Fass DE, Armstrong JG, Sessions RB, Shah JP, Spiro RH, Strong EW, Weisen S, Bosl GJ. Harrison LB, et al. Among authors: bosl gj. Int J Radiat Oncol Biol Phys. 1991 Aug;21(3):703-8. doi: 10.1016/0360-3016(91)90689-2. Int J Radiat Oncol Biol Phys. 1991. PMID: 1869464

9

Very-high-dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer.

Haines I, Bosl G, Pfister D, Spiro R, Gerold F, Sessions R, Shah J, Strong E, Vikram B, Harrison L. Haines I, et al. Among authors: bosl g. J Clin Oncol. 1987 Oct;5(10):1594-600. doi: 10.1200/JCO.1987.5.10.1594. J Clin Oncol. 1987. PMID: 2443621 Clinical Trial.

10

Blood group-related antigens in human germ cell tumors.

Motzer RJ, Reuter VE, Cordon-Cardo C, Bosl GJ. Motzer RJ, et al. Among authors: bosl gj. Cancer Res. 1988 Sep 15;48(18):5342-7. Cancer Res. 1988. PMID: 3044584

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

333 results

Search Page

Filters